Le Guen, Pierre
Chevret, Sylvie
Bugnet, Emmanuelle
de Margerie-Mellon, Constance
Lorillon, Gwenaël
Seguin-Givelet, Agathe
Jouenne, Fanélie
Gossot, Dominique
Vassallo, Robert
Tazi, Abdellatif http://orcid.org/0000-0003-0788-7444
Article History
Received: 1 July 2019
Accepted: 13 September 2019
First Online: 21 October 2019
Ethics approval and consent to participate
: The study was performed in accordance with the Helsinki Declaration and approved by the Institutional Review Board of the French Institute of Medical Research and Health (IRB number17–395). All patients provided written informed consent for the use of their medical reports for research.
: Not applicable.
: Dr. Le Guen declares travel accommodations from LVL Medical and Novartis.Dr. Chevret has no conflicts of interest to declare.Dr. Bugnet has no conflicts of interest to declare.Dr. de Margerie-Mellon has received grants from Institut Servier and Olea Medical.Dr. Lorillon declares travel accommodations from Vitalaire and Chiesi.Dr. Seguin-Givelet has no conflicts of interest to declare.Dr. Jouenne has no conflicts of interest to declare.Dr. Gossot has no conflicts of interest to declare.Dr. Vassallo has received research funding from Pfizer, Bristol Myers Squibb, and Sun Pharma.Dr. Tazi declares speaker fees from BMS and travel accommodations from Boehringer Ingelheim, Astrazeneca, Vitalaire and Teva.